Full Access with Signal8 Pro, $49/mo billed annually.
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
Sector: Blank Checks
Industry: Shell Companies
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 3.17M shares outstanding
Aimei Health Technology Co., Ltd does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Jia Zhao
Director
Jing Yang
General Manager and Legal Representative of Yixun Chuangneng
Julianne Huh
Director
Junheng Xie
Chief Executive Officer, Secretary & Director
Employees
2
Country
US
Sector
Financial Services
Website
aimeihealth.com
Loading congressional disclosures…
based on 3.17M shares outstanding
30d Avg
3.78K
60d Avg
19.10K
90d Avg
23.19K